Lebanon has recorded its first case of the often-fatal Middle East respiratory virus, the Health Ministry said Friday.
The virus was detected Thursday in a man who had checked into a local hospital after feeling ill, the ministry said. It said the case was not severe, and the man has since been discharged.
A ministry official said the patient had recently returned from a visit to several Gulf countries, including Saudi Arabia.
The kingdom has been the focal point of the outbreak of the virus, known as the Middle East Respiratory Syndrome.
MERS belongs to a family of viruses that include both the common cold and SARS, which killed some 800 people in a global outbreak in 2003. It can cause symptoms that include fever, breathing problems, pneumonia and kidney failure.
Not everyone who contracts the virus that causes MERS gets sick, while others show only mild symptoms. There is no cure or vaccine.
Still, the threat from the virus has prompted health officials around the region to adopt protective measures to try to prevent the spread of the disease.
In Lebanon, the health minister on Thursday ordered that thermal cameras be set up at Beirut's international airport to check arriving passengers for possible signs of fever, indicating a possible MERS infection.
Five more people have died in Saudi Arabia after contracting an often fatal Middle East respiratory virus as the number of new infections in the kingdom climbs higher, health officials confirmed Thursday.
People with higher levels of antibodies against the stem portion of the influenza virus hemagglutinin (HA) protein have less viral shedding when they get the flu, but do not have fewer or less severe signs of illness, according ...
A new study, published in Nature Communications, conducted by the University of Liverpool and the Johns Hopkins University School of Medicine highlights a new 'long acting' medicine for the prevention of malaria.
A major review by UNSW researchers has identified strong evidence that a virus called Enterovirus D68 is the cause of a mystery polio-like illness that has paralysed children in the US, Canada and Europe.
UAlberta researchers created a new synthetic virus that could lead to the development of a more effective vaccine against smallpox. The discovery demonstrates how techniques based on the use of synthetic DNA can be used to ...
More than 700,000 Americans were hospitalized due to illnesses associated with the seasonal flu during the 2014-15 flu season, according to federal estimates. A radical new approach to vaccine development at UCLA may help ...
Please sign in to add a comment.
Registration is free, and takes less than a minute.
Click here to reset your password.
Sign in to get notified via email when new comments are made.